Updates are available Correction dated 2025-06-11
Click to view Correction: https://doi.org/10.1186/s42466-025-00397-w
-
Authors
Weil, Jenny
Linka, Louise
Gurschi, Mariana
Kidik, Seyyid Abdulkerim
Fuchs, Alena
Schoenfeldt, Rebecca
Zahnert, Felix
Möller, Leona
Menzler, Katja
Kemmling, André
Knake, Susanne
Habermehl, Lena https://orcid.org/0000-0003-0290-7784
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct06836687 at ClinicalTrials.govDocuments that mention this clinical trial
The impact of white matter lesions on seizure recurrence after first epileptic seizures in the elderly: a prospective study
https://doi.org/10.1186/s42466-025-00391-2
-
Funding
Funding for this research was provided by:
Philipps-Universität Marburg
- License Information
-
More Information
Article History
Received: 18 February 2025
Accepted: 25 April 2025
First Online: 20 May 2025
Change Date: 11 June 2025
Change Type: Update
Change Details: The original online version of this article was revised: due to a typesetting mistake, the values in the rows ‘Tumor/Metastasis’ and ‘Hippocampal sclerosis’ in Table 1 were incorrectly given.
Change Date: 11 June 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s42466-025-00397-w
Declarations
:
: The study was approved by the local ethics committee (Ethikkommission Marburg, AZ 199/17). All patients provided their consent to participate in the study and to the publication of the results. We confirm that we have read the Journal’s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.
: Not applicable.
: KM has received speaker's fees from KM reports and scientific advisory board honoraria from Eisai, Bial, UCB Pharma and JAZZ pharmaceuticals. SK has received speaker´s honoraria from Bial, Eisai, Kanso, Merck Serono and UCB Pharma. LH has received traveling expenses from Angelini Pharma and is funded by the German epilepsy society (DGfE). The remaining authors have no conflicts of interest.
